Screener
Bausch Health Companies BHC Bausch + Lomb — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | Three Months Ended March 31, / Salix / 2026 | Three Months Ended March 31, / Salix / 2025 | Three Months Ended March 31, / International / 2026 | Three Months Ended March 31, / International / 2025 | Three Months Ended March 31, / Solta Medical / 2026 | Three Months Ended March 31, / Solta Medical / 2025 | Three Months Ended March 31, / Diversified / 2026 | Three Months Ended March 31, / Diversified / 2025 | Three Months Ended March 31, / Bausch + Lomb / 2026 | Three Months Ended March 31, / Bausch + Lomb / 2025 | Three Months Ended March 31, / Total / 2026 | Total / 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of other revenues | — | — | 16 | 17 | — | — | — | — | 1 | 1 | ||
| Selling, general and administrative | 105 | 111 | 63 | 52 | 35 | 28 | 43 | 45 | 439 | 447 | ||
| Research and development | 19 | 17 | 6 | 6 | 8 | 5 | 3 | 3 | 45 | 28 | ||
| Segment profit | $468 | $371 | $88 | $85 | $75 | $53 | $112 | $127 | $277 | $180 | $1,020 | $816 |
| Corporate | (258) | (268) | ||||||||||
| Amortization of intangible assets | (241) | (256) | ||||||||||
| Goodwill impairments | (1,426) | — | ||||||||||
| Restructuring, integration and separation costs | (13) | (1) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's bausch + lomb — operating income (loss)?
- Bausch Health Companies (BHC) reported bausch + lomb — operating income (loss) of $277M in Q1 2026.
- How has Bausch Health Companies's bausch + lomb — operating income (loss) changed year-over-year?
- Bausch Health Companies's bausch + lomb — operating income (loss) increased by 53.9% year-over-year, from $180M to $277M.
- What is the long-term trend for Bausch Health Companies's bausch + lomb — operating income (loss)?
- Over 4 years (2021 to 2025), Bausch Health Companies's bausch + lomb — operating income (loss) has grown at a 4.1% compound annual growth rate (CAGR), from $958M to $1.13B.
- What does bausch + lomb — operating income (loss) mean?
- Measures the profitability of the Bausch + Lomb segment by subtracting operating expenses from total segment revenues. It provides a clear view of the segment's core operational performance before accounting for interest, taxes, and corporate-level financial decisions.
Ask your AI about Bausch Health Companies's bausch + lomb — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude